The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Vinpocetine-Global Market Insights and Sales Trends 2025
Synopsis
Vinpocetine is a synthetic derivative of the vinca alkaloid vincamine, an extract from the lesser periwinkle plant. Vinpocetine was first isolated from the plant in 1975 by the Hungarian chemist Csaba Szántay. The mass production of the synthetic compound was started in 1978 by the Hungarian pharmaceutical company Richter Gedeon. The indications is improvement all symptoms of cerebral infarction and cerebral hemorrhage sequela, cerebrovascular atherosclerosis
Vinpocetine is not FDA approved in the United States for therapeutic use. The U.S. Food & Drug Administration (FDA) has ruled that vinpocetine, due to its synthetic nature and proposed therapeutic uses, was ineligible to be marketed as dietary supplement under the Federal Food, Drug, and Cosmetic Act (FDCA).
The global Vinpocetine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Vinpocetine in various end use industries. The expanding demands from the Household and Hospital, are propelling Vinpocetine market. Tablet, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injection segment is estimated at % CAGR for the next seven-year period.
In the US market, the major manufacturers are Gedeon Richter, Runhong, Sun Pharma, WZT, Pude, Welman and Zhitong.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Vinpocetine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Vinpocetine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Vinpocetine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Vinpocetine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Vinpocetine covered in this report include Gedeon Richter, Runhong, Sun Pharma, WZT, PUDE, Welman, ZhiTong, Liaoning Zhiying and COVEX, etc.
The global Vinpocetine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Gedeon Richter
Runhong
Sun Pharma
WZT
PUDE
Welman
ZhiTong
Liaoning Zhiying
COVEX
Northeast Pharma
Micro Labs
Global Vinpocetine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Vinpocetine market, Segment by Type:
Tablet
Injection
Global Vinpocetine market, by Application
Household
Hospital
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Vinpocetine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Vinpocetine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Vinpocetine is a synthetic derivative of the vinca alkaloid vincamine, an extract from the lesser periwinkle plant. Vinpocetine was first isolated from the plant in 1975 by the Hungarian chemist Csaba Szántay. The mass production of the synthetic compound was started in 1978 by the Hungarian pharmaceutical company Richter Gedeon. The indications is improvement all symptoms of cerebral infarction and cerebral hemorrhage sequela, cerebrovascular atherosclerosis
Vinpocetine is not FDA approved in the United States for therapeutic use. The U.S. Food & Drug Administration (FDA) has ruled that vinpocetine, due to its synthetic nature and proposed therapeutic uses, was ineligible to be marketed as dietary supplement under the Federal Food, Drug, and Cosmetic Act (FDCA).
The global Vinpocetine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Vinpocetine in various end use industries. The expanding demands from the Household and Hospital, are propelling Vinpocetine market. Tablet, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injection segment is estimated at % CAGR for the next seven-year period.
In the US market, the major manufacturers are Gedeon Richter, Runhong, Sun Pharma, WZT, Pude, Welman and Zhitong.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Vinpocetine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Vinpocetine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Vinpocetine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Vinpocetine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Vinpocetine covered in this report include Gedeon Richter, Runhong, Sun Pharma, WZT, PUDE, Welman, ZhiTong, Liaoning Zhiying and COVEX, etc.
The global Vinpocetine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Gedeon Richter
Runhong
Sun Pharma
WZT
PUDE
Welman
ZhiTong
Liaoning Zhiying
COVEX
Northeast Pharma
Micro Labs
Global Vinpocetine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Vinpocetine market, Segment by Type:
Tablet
Injection
Global Vinpocetine market, by Application
Household
Hospital
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Vinpocetine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Vinpocetine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Vinpocetine Market Overview
1.1 Vinpocetine Product Overview
1.2 Vinpocetine Market Segment by Type
1.2.1 Tablet
1.2.2 Injection
1.3 Global Vinpocetine Market Size by Type
1.3.1 Global Vinpocetine Market Size Overview by Type (2018-2029)
1.3.2 Global Vinpocetine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Vinpocetine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Vinpocetine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Vinpocetine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Vinpocetine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Vinpocetine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Vinpocetine Sales Breakdown by Type (2018-2023)
2 Global Vinpocetine Market Competition by Company
2.1 Global Top Players by Vinpocetine Sales (2018-2023)
2.2 Global Top Players by Vinpocetine Revenue (2018-2023)
2.3 Global Top Players by Vinpocetine Price (2018-2023)
2.4 Global Top Manufacturers Vinpocetine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Vinpocetine Market Competitive Situation and Trends
2.5.1 Vinpocetine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Vinpocetine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vinpocetine as of 2022)
2.7 Date of Key Manufacturers Enter into Vinpocetine Market
2.8 Key Manufacturers Vinpocetine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Vinpocetine Status and Outlook by Region
3.1 Global Vinpocetine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Vinpocetine Historic Market Size by Region
3.2.1 Global Vinpocetine Sales in Volume by Region (2018-2023)
3.2.2 Global Vinpocetine Sales in Value by Region (2018-2023)
3.2.3 Global Vinpocetine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Vinpocetine Forecasted Market Size by Region
3.3.1 Global Vinpocetine Sales in Volume by Region (2024-2029)
3.3.2 Global Vinpocetine Sales in Value by Region (2024-2029)
3.3.3 Global Vinpocetine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Vinpocetine by Application
4.1 Vinpocetine Market Segment by Application
4.1.1 Household
4.1.2 Hospital
4.2 Global Vinpocetine Market Size by Application
4.2.1 Global Vinpocetine Market Size Overview by Application (2018-2029)
4.2.2 Global Vinpocetine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Vinpocetine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Vinpocetine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Vinpocetine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Vinpocetine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Vinpocetine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Vinpocetine Sales Breakdown by Application (2018-2023)
5 North America Vinpocetine by Country
5.1 North America Vinpocetine Historic Market Size by Country
5.1.1 North America Vinpocetine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Vinpocetine Sales in Volume by Country (2018-2023)
5.1.3 North America Vinpocetine Sales in Value by Country (2018-2023)
5.2 North America Vinpocetine Forecasted Market Size by Country
5.2.1 North America Vinpocetine Sales in Volume by Country (2024-2029)
5.2.2 North America Vinpocetine Sales in Value by Country (2024-2029)
6 Europe Vinpocetine by Country
6.1 Europe Vinpocetine Historic Market Size by Country
6.1.1 Europe Vinpocetine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Vinpocetine Sales in Volume by Country (2018-2023)
6.1.3 Europe Vinpocetine Sales in Value by Country (2018-2023)
6.2 Europe Vinpocetine Forecasted Market Size by Country
6.2.1 Europe Vinpocetine Sales in Volume by Country (2024-2029)
6.2.2 Europe Vinpocetine Sales in Value by Country (2024-2029)
7 Asia-Pacific Vinpocetine by Region
7.1 Asia-Pacific Vinpocetine Historic Market Size by Region
7.1.1 Asia-Pacific Vinpocetine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Vinpocetine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Vinpocetine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Vinpocetine Forecasted Market Size by Region
7.2.1 Asia-Pacific Vinpocetine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Vinpocetine Sales in Value by Region (2024-2029)
8 Latin America Vinpocetine by Country
8.1 Latin America Vinpocetine Historic Market Size by Country
8.1.1 Latin America Vinpocetine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Vinpocetine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Vinpocetine Sales in Value by Country (2018-2023)
8.2 Latin America Vinpocetine Forecasted Market Size by Country
8.2.1 Latin America Vinpocetine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Vinpocetine Sales in Value by Country (2024-2029)
9 Middle East and Africa Vinpocetine by Country
9.1 Middle East and Africa Vinpocetine Historic Market Size by Country
9.1.1 Middle East and Africa Vinpocetine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Vinpocetine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Vinpocetine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Vinpocetine Forecasted Market Size by Country
9.2.1 Middle East and Africa Vinpocetine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Vinpocetine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Gedeon Richter
10.1.1 Gedeon Richter Company Information
10.1.2 Gedeon Richter Introduction and Business Overview
10.1.3 Gedeon Richter Vinpocetine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Gedeon Richter Vinpocetine Products Offered
10.1.5 Gedeon Richter Recent Development
10.2 Runhong
10.2.1 Runhong Company Information
10.2.2 Runhong Introduction and Business Overview
10.2.3 Runhong Vinpocetine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Runhong Vinpocetine Products Offered
10.2.5 Runhong Recent Development
10.3 Sun Pharma
10.3.1 Sun Pharma Company Information
10.3.2 Sun Pharma Introduction and Business Overview
10.3.3 Sun Pharma Vinpocetine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Sun Pharma Vinpocetine Products Offered
10.3.5 Sun Pharma Recent Development
10.4 WZT
10.4.1 WZT Company Information
10.4.2 WZT Introduction and Business Overview
10.4.3 WZT Vinpocetine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 WZT Vinpocetine Products Offered
10.4.5 WZT Recent Development
10.5 PUDE
10.5.1 PUDE Company Information
10.5.2 PUDE Introduction and Business Overview
10.5.3 PUDE Vinpocetine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 PUDE Vinpocetine Products Offered
10.5.5 PUDE Recent Development
10.6 Welman
10.6.1 Welman Company Information
10.6.2 Welman Introduction and Business Overview
10.6.3 Welman Vinpocetine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Welman Vinpocetine Products Offered
10.6.5 Welman Recent Development
10.7 ZhiTong
10.7.1 ZhiTong Company Information
10.7.2 ZhiTong Introduction and Business Overview
10.7.3 ZhiTong Vinpocetine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 ZhiTong Vinpocetine Products Offered
10.7.5 ZhiTong Recent Development
10.8 Liaoning Zhiying
10.8.1 Liaoning Zhiying Company Information
10.8.2 Liaoning Zhiying Introduction and Business Overview
10.8.3 Liaoning Zhiying Vinpocetine Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Liaoning Zhiying Vinpocetine Products Offered
10.8.5 Liaoning Zhiying Recent Development
10.9 COVEX
10.9.1 COVEX Company Information
10.9.2 COVEX Introduction and Business Overview
10.9.3 COVEX Vinpocetine Sales, Revenue and Gross Margin (2018-2023)
10.9.4 COVEX Vinpocetine Products Offered
10.9.5 COVEX Recent Development
10.10 Northeast Pharma
10.10.1 Northeast Pharma Company Information
10.10.2 Northeast Pharma Introduction and Business Overview
10.10.3 Northeast Pharma Vinpocetine Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Northeast Pharma Vinpocetine Products Offered
10.10.5 Northeast Pharma Recent Development
10.11 Micro Labs
10.11.1 Micro Labs Company Information
10.11.2 Micro Labs Introduction and Business Overview
10.11.3 Micro Labs Vinpocetine Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Micro Labs Vinpocetine Products Offered
10.11.5 Micro Labs Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Vinpocetine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Vinpocetine Industrial Chain Analysis
11.4 Vinpocetine Market Dynamics
11.4.1 Vinpocetine Industry Trends
11.4.2 Vinpocetine Market Drivers
11.4.3 Vinpocetine Market Challenges
11.4.4 Vinpocetine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Vinpocetine Distributors
12.3 Vinpocetine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
